InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.verified

INM

Price:

$1.34

Market Cap:

$2.43M

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosyn...[Read more]

Industry

Biotechnology

IPO Date

2014-05-05

Stock Exchange

NASDAQ

Ticker

INM

The PE Ratio as of December 2025 (TTM) for InMed Pharmaceuticals Inc. (INM) is -0.22

According to InMed Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.22. This represents a change of -40.27% compared to the average of -0.37 of the last 4 quarters.

InMed Pharmaceuticals Inc. (INM) Historical PE Ratio (quarterly & annually)

How has INM PE Ratio performed in the past?

The mean historical PE Ratio of InMed Pharmaceuticals Inc. over the last ten years is -8.31. The current -0.22 PE Ratio has changed 164.68% with respect to the historical average. Over the past ten years (40 quarters), INM's PE Ratio was at its highest in in the March 2025 quarter at -0.26. The PE Ratio was at its lowest in in the December 2017 quarter at -97.27.

Quarterly (TTM)
Annual

Average

-8.31

Median

-5.40

Minimum

-32.11

Maximum

-0.37

InMed Pharmaceuticals Inc. (INM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of InMed Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 161.28%

Maximum Annual PE Ratio = -0.37

Minimum Annual Increase = -86.87%

Minimum Annual PE Ratio = -32.11

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.396.44%
2024-0.37-15.20%
2023-0.43-21.74%
2022-0.55-86.87%
2021-4.19-57.17%
2020-9.78-14.48%
2019-11.44-64.37%
2018-32.1186.05%
2017-17.26161.28%
2016-6.6117.39%

InMed Pharmaceuticals Inc. (INM) Average PE Ratio

How has INM PE Ratio performed in the past?

The current PE Ratio of InMed Pharmaceuticals Inc. (INM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.39

5-year avg

-1.18

10-year avg

-8.31

InMed Pharmaceuticals Inc. (INM) PE Ratio vs. Peers

How is INM’s PE Ratio compared to its peers?

InMed Pharmaceuticals Inc.’s PE Ratio is less than Biodexa Pharmaceuticals Plc (-0.00), less than Genprex, Inc. (-0.15), greater than BioVie Inc. (-0.45), greater than Galmed Pharmaceuticals Ltd. (-0.51), greater than GRI Bio, Inc. (-0.47), less than CNS Pharmaceuticals, Inc. (-0.02), less than Jaguar Health, Inc. (-0.04), greater than Estrella Immunopharma, Inc. (-5.78), greater than Silo Pharma, Inc. (-0.83), greater than Kazia Therapeutics Limited (-0.74),

Build a custom stock screener for InMed Pharmaceuticals Inc. (INM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InMed Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InMed Pharmaceuticals Inc. (INM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InMed Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is InMed Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for InMed Pharmaceuticals Inc. (INM)?

What is the highest PE Ratio for InMed Pharmaceuticals Inc. (INM)?

What is the 3-year average PE Ratio for InMed Pharmaceuticals Inc. (INM)?

What is the 5-year average PE Ratio for InMed Pharmaceuticals Inc. (INM)?

How does the current PE Ratio for InMed Pharmaceuticals Inc. (INM) compare to its historical average?